Ivar Mendez1, Michael Song, Paula Chiasson, Luis Bustamante. 1. Neuromodulation and Remote Medicine Program, Capital Health Division of Neurosurgery, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. mendez@dal.ca
Abstract
BACKGROUND: The expansion of neuromodulation and its indications has resulted in hundreds of thousands of patients with implanted devices worldwide. Because all patients require programming, this growth has created a heavy burden on neuromodulation centers and patients. Remote point-of-care programming may provide patients with real-time access to neuromodulation expertise in their communities. OBJECTIVE: To test the feasibility of remotely programming a neuromodulation device using a remote-presence robot and to determine the ability of an expert programmer to telementor a nonexpert in programming the device. METHODS: A remote-presence robot (RP-7) was used for remote programming. Twenty patients were randomly assigned to either conventional programming or a robotic session. The expert remotely mentored 10 nurses with no previous experience to program the devices of patients assigned to the remote-presence sessions. Accuracy of programming, adverse events, and satisfaction scores for all participants were assessed. RESULTS: There was no difference in the accuracy or clinical outcomes of programming between the standard and remote-presence sessions. No adverse events occurred in any session. The patients, nurses, and the expert programmer expressed high satisfaction scores with the remote-presence sessions. CONCLUSION: This study establishes the proof-of-principle that remote programming of neuromodulation devices using telepresence and expert telementoring of an individual with no previous experience to accurately program a device is feasible. We envision a time in the future when patients with implanted devices will have real-time access to neuromodulation expertise from the comfort of their own home.
RCT Entities:
BACKGROUND: The expansion of neuromodulation and its indications has resulted in hundreds of thousands of patients with implanted devices worldwide. Because all patients require programming, this growth has created a heavy burden on neuromodulation centers and patients. Remote point-of-care programming may provide patients with real-time access to neuromodulation expertise in their communities. OBJECTIVE: To test the feasibility of remotely programming a neuromodulation device using a remote-presence robot and to determine the ability of an expert programmer to telementor a nonexpert in programming the device. METHODS: A remote-presence robot (RP-7) was used for remote programming. Twenty patients were randomly assigned to either conventional programming or a robotic session. The expert remotely mentored 10 nurses with no previous experience to program the devices of patients assigned to the remote-presence sessions. Accuracy of programming, adverse events, and satisfaction scores for all participants were assessed. RESULTS: There was no difference in the accuracy or clinical outcomes of programming between the standard and remote-presence sessions. No adverse events occurred in any session. The patients, nurses, and the expert programmer expressed high satisfaction scores with the remote-presence sessions. CONCLUSION: This study establishes the proof-of-principle that remote programming of neuromodulation devices using telepresence and expert telementoring of an individual with no previous experience to accurately program a device is feasible. We envision a time in the future when patients with implanted devices will have real-time access to neuromodulation expertise from the comfort of their own home.
Authors: Daniel G Eichberg; Gregory W Basil; Long Di; Ashish H Shah; Evan M Luther; Victor M Lu; Maggy Perez-Dickens; Ricardo J Komotar; Allan D Levi; Michael E Ivan Journal: Neurosurgery Date: 2020-12-15 Impact factor: 4.654
Authors: Timothy R Deer; Michael F Esposito; Eric G Cornidez; Udoka Okaro; Marie E Fahey; Kenneth B Chapman Journal: J Pain Res Date: 2021-10-14 Impact factor: 3.133
Authors: Alexander F Haddad; John F Burke; Praveen V Mummaneni; Andrew K Chan; Michael M Safaee; John J Knightly; Rory R Mayer; Brenton H Pennicooke; Anthony M Digiorgio; Philip R Weinstein; Aaron J Clark; Dean Chou; Sanjay S Dhall Journal: Neurospine Date: 2021-06-30